These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31348785)

  • 21. Rapid endocytosis of interleukin-15 by cerebral endothelia.
    Stone KP; Kastin AJ; Hsuchou H; Yu C; Pan W
    J Neurochem; 2011 Feb; 116(4):544-53. PubMed ID: 21155807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral microvascular IL15 is a novel mediator of TNF action.
    Pan W; Yu C; Hsuchou H; Khan RS; Kastin AJ
    J Neurochem; 2009 Nov; 111(3):819-27. PubMed ID: 19719822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action.
    Dubois S; Patel HJ; Zhang M; Waldmann TA; Müller JR
    J Immunol; 2008 Feb; 180(4):2099-106. PubMed ID: 18250415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanometer-scale organization of the alpha subunits of the receptors for IL2 and IL15 in human T lymphoma cells.
    de Bakker BI; Bodnár A; van Dijk EM; Vámosi G; Damjanovich S; Waldmann TA; van Hulst NF; Jenei A; Garcia-Parajo MF
    J Cell Sci; 2008 Mar; 121(Pt 5):627-33. PubMed ID: 18287585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted delivery of calreticulin to ED-A fibronectin leads to tumor-growth retardation.
    Ziffels B; Grötsch A; Al-Bayati L; Neri D
    J Biotechnol; 2019 Jan; 290():53-58. PubMed ID: 30579890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a recombinant human IL-15·sIL-15Rα/Fc superagonist with improved half-life and its antitumor activity alone or in combination with PD-1 blockade in mouse model.
    Zhao M; Luo M; Xie Y; Jiang H; Cagliero C; Li N; Ye H; Wu M; Hao S; Sun T; Yang H; Zhang M; Lin T; Lu H; Zhu J
    Biomed Pharmacother; 2019 Apr; 112():108677. PubMed ID: 30798123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL15 promotes growth and invasion of endometrial stromal cells and inhibits killing activity of NK cells in endometriosis.
    Yu JJ; Sun HT; Zhang ZF; Shi RX; Liu LB; Shang WQ; Wei CY; Chang KK; Shao J; Wang MY; Li MQ
    Reproduction; 2016 Aug; 152(2):151-60. PubMed ID: 27190213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models.
    Rhode PR; Egan JO; Xu W; Hong H; Webb GM; Chen X; Liu B; Zhu X; Wen J; You L; Kong L; Edwards AC; Han K; Shi S; Alter S; Sacha JB; Jeng EK; Cai W; Wong HC
    Cancer Immunol Res; 2016 Jan; 4(1):49-60. PubMed ID: 26511282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha.
    Bouchaud G; Garrigue-Antar L; Solé V; Quéméner A; Boublik Y; Mortier E; Perdreau H; Jacques Y; Plet A
    J Mol Biol; 2008 Sep; 382(1):1-12. PubMed ID: 18656487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced half-life and antitumor activity of interleukin-15 through genetic fusion of a serum albumin-specific protein binder.
    Kim D; Park JH; Kim TY; Kim DG; Byun JH; Kim HS
    Int J Pharm; 2022 Sep; 625():122059. PubMed ID: 35905933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy.
    Waldmann TA
    Cancer Immunol Res; 2015 Mar; 3(3):219-27. PubMed ID: 25736261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
    Jiang W; Zhang C; Tian Z; Zhang J
    Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of interleukin 15 in neoplasia.
    Chłopek M; Kowalik A; Góźdź S; Koziak K
    Postepy Hig Med Dosw (Online); 2017 Jan; 71(0):5-19. PubMed ID: 28181907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy.
    Mårlind J; Kaspar M; Trachsel E; Sommavilla R; Hindle S; Bacci C; Giovannoni L; Neri D
    Clin Cancer Res; 2008 Oct; 14(20):6515-24. PubMed ID: 18927291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An activation-induced IL-15 isoform is a natural antagonist for IL-15 function.
    Zhao L; Hu B; Zhang Y; Song Y; Lin D; Liu Y; Mei Y; Sandikin D; Sun W; Zhuang M; Liu H
    Sci Rep; 2016 May; 6():25822. PubMed ID: 27166125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different tissue distribution properties for glycosylation variants of fusion proteins containing the p40 subunit of murine interleukin-12.
    Bootz F; Venetz D; Ziffels B; Neri D
    Protein Eng Des Sel; 2016 Oct; 29(10):445-455. PubMed ID: 27515704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. hIL-15-gene modified human natural killer cells (NKL-IL15) exhibit anti-human leukemia functions.
    Jiang W; Zhang C; Tian Z; Zhang J
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1279-1288. PubMed ID: 29737430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning and expression of feline interleukin 15.
    Dean GA; Barger A; Lavoy A
    Cytokine; 2005 Jan; 29(2):77-83. PubMed ID: 15598442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor targeting properties of antibody fusion proteins based on different members of the murine tumor necrosis superfamily.
    Hemmerle T; Hess C; Venetz D; Neri D
    J Biotechnol; 2014 Feb; 172():73-6. PubMed ID: 24384233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model.
    Niu Z; Bai F; Sun T; Tian H; Yu D; Yin J; Li S; Li T; Cao H; Yu Q; Wu Y; Ren G; Li D
    Technol Cancer Res Treat; 2015 Oct; 14(5):607-15. PubMed ID: 24645750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.